Giuseppe Lippi/LinkedIn
Oct 10, 2025, 03:09
Giuseppe Lippi: We Show Here That Red Light Therapy Offers Promise in High-Risk Patients
Giuseppe Lippi, Dean of Medicine at the University of Verona, shared on LinkedIn:
”We show here that red light therapy offers promise in high-risk patients where conventional anticoagulation is limited by bleeding risk.
Fan BE, Pasalic L, Lippi G, Hew YY, Favaloro EJ. Red Light Therapy in Thrombosis and Hemostasis. Semin Thromb Hemost. 2025 Oct 8. doi: 10.1055/a-2717-5157. Epub ahead of print.”
Read the full article in Seminars in Thrombosis and Hemostasis.
Article: Red Light Therapy in Thrombosis and Hemostasis
Authors: Bingwen Eugene Fan , Leonardo Pasalic, Giuseppe Lippi , Yu Yue Hew, Emmanuel J. Favaloro
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Sep 19, 2026, 14:17Abdul Mannan: What Exactly Is a Platelet?
-
Sep 19, 2026, 13:39Keisuke Goda: Decoding Platelet Phenotypes in COVID-19 With Optofluidic Imaging
-
Sep 19, 2026, 13:30Targeted Thrombolysis Beyond tPA
-
Sep 19, 2026, 13:21Paul Armstrong: From Summer Studentship to Young Researcher
-
Sep 19, 2026, 13:06Rabiya Masood: Breaking the Cycle of Thalassemia Through Screening
-
Sep 19, 2026, 10:52Consuela A. Albright: The Critical Role of Black Blood Donors in Sickle Cell Treatment
-
Sep 19, 2026, 10:47Amber Yates: Inside Agios’ Partnership with the Sickle Cell Community
-
Sep 19, 2026, 10:46Anton Farkas: Mechanical Thrombectomy for Acute PE in Early Pregnancy
-
Sep 19, 2026, 10:40Marjolein Smidt: ASH Raises Ferritin Thresholds for Iron Deficiency